Compare H2O America (HTO) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
H2O America vs Tempus AI — how do they compare? H2O America trades at $58.31 (market cap $2.43B), while Tempus AI trades at $70.03 (market cap $12.58B). The key difference: Tempus AI is far larger — about 5.2× H2O America's market cap, and H2O America pays a 3.03% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold H2O America for 40 Days and Tempus AI for 22 Days on average.
| HTO | TEM | |
|---|---|---|
Market Cap | $2.43B | $12.58B |
Volume | 593,883 | 7,444,569 |
Sector | Utilities | Broad Market / Factor |
52-Week High | $65.43 | $99.28 |
52-Week Low | $44.44 | $41.55 |
Typical Hold Time | 40 Days | 22 Days |
Enterprise Value | $4.22B | $13.21B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HTO trades at $57.98, down 0.34% today, with a bearish technical signal despite bullish oscillators. The company maintains strong profitability with 12.91% net margin and recently completed the Quadvest acquisition in Texas. Earnings show mixed performance with Q2 2026 beating expectations but Q4 2025 missing estimates.
Analyst consensus remains bullish with 83% buy ratings and $66.50 price target, representing 15% upside. Key risks include acquisition integration challenges and negative cash flow from investing activities. The stock offers dividend income with recent $0.44 dividend declaration.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About H2O America
H2O America is a utility company that provides essential water and wastewater services, primarily in the United States. The company operates a network of regulated water and wastewater systems, focusing on responsible resource management and high-quality service delivery. HTO aims to expand its operational footprint through acquisitions and internal growth, serving residential, commercial, and industrial customers.
Read more on HTO →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
